• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    21.59 Down 0.27(1.24%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:21.86
    Open:21.88
    Bid:15.36 x 100
    Ask:N/A
    1y Target Est:34.38
    Beta:-0.28
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:21.50 - 22.05
    52wk Range:19.10 - 74.58
    Volume:212,805
    Avg Vol (3m):1,240,580
    Market Cap:613.91M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.24%613.91M
    AZNUp 0.37%88.97B
    MRKUp 0.44%163.81B
    PFEDown 0.10%197.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.99
    Quarterly EPS Est (Dec-14) :-0.03
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-1.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback